Kenney Christopher John
CIK 0001880129
Chief Medical Officer
Filings
9
Latest Mar 13, 2026
Issuers covered
1
Showing
9 of 9
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 50% | +1.0% | -1.4% | +18.8% | -12.0% |
| 90 days | 2 | 50% | +4.9% | +4.9% | +25.8% | -16.0% |
| 180 days | 2 | 50% | +14.1% | +14.1% | +30.4% | -2.3% |
| 365 days | 2 | 50% | +8.6% | +8.6% | +39.0% | -21.8% |
Issuers
Companies where Kenney Christopher John has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 9 | Mar 13, 2026 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|